Serum prolactin and response to treatment among cocaine-dependent individuals

Addiction Biology

Volumn 7, Issue 1, 2002, Pages 45-53

  Patkar, Ashwin A ^a   Hill, Kevin P ^a   Sterling, Robert C ^a   Gottheil, Edward ^a   Berrettini, Wade H ^b   Weinstein, Stephen P ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PROLACTIN;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORRELATION FUNCTION; DOPAMINERGIC ACTIVITY; FEMALE; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AMBULATORY CARE; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; PATIENT DROPOUTS; PERSONALITY INVENTORY; PROGNOSIS; PROLACTIN; RECEPTORS, DOPAMINE; REFERENCE VALUES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036155532     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/135562101200100599     Document Type: Article

References (45)

1. Cocaine receptor: Biochemical characterization and structure activity relationships of cocaine analogues at the dopamine transporter
2. The dopamine hypothesis of the reinforcing properties of cocaine
3. Role for the mesocortical dopamine system in the motivating effects of cocaine
4. New concepts in cocaine addiction: The dopamine depletion hypothesis
5. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited access self-administration
6. Neuroendocrine findings in chronic cocaine abusers: A preliminary report
7. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantidine or desipramine
8. Molecular and cellular basis of addiction
9. Cocaine's effects on neuroendocrine systems: Clinical and preclinical studies
10. Dopamine in hypophysial stalk blood of the rhesus monkey and its role in regulating prolactin secretion
11. Neurotransmitter regulation of anterior pituitary hormones
12. Circulating gonadotropin profile in severe cases of protein calorie malnutrition
13. Regulation of prolactin secretion and its disorders
14. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers
15. Monoaminergic regulation of neuroendocrine function and its modification by cocaine
16. Effects of acute and chronic cocaine on the activity of the tuberoinfundibular dopamine neurons in the rat
17. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal
18. Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients
19. Hyperprolactinemia and risk for relapse of cocaine abuse
20. Dopaminergic responsivity during cocaine abstinence: A pilot study
21. Neuroendocrine measures of dopaminergic function in chronic cocaine users
22. Serum prolactin levels during extended cocaine abstinence
23. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers
24. Pretreatment dropouts: Characteristics and outcomes
25. Treatment outcomes in inpatient and substance abuse programs
26. Serum prolactin levels and treatment outcome in cocaine dependence
27. New data from the Addiction Severity Index: Reliability and validity in three centers
28. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
29. Measurement of serum ferritin by a two-site immunoradiometric assay
30. Interpersonal psychotherapy adapted for ambulatory cocaine abusers
31. Cocaine dependence: Alcohol and other drug dependence and withdrawal characteristics
32. Sexual dysfunction secondary to cocaine abuse in two patients
33. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications
34. Nicotine from cigarette smoke increases circulating levels of cortisol, growth hormone and prolactin in chronic male smokers
35. Endocrine responses during acute nicotine withdrawal
36. The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia
37. Efficacy of outpatient intensive treatment for drug abuse
38. Prediction of discharges against medical advice from an alcohol and drug misuse treatment program
39. Dropping out of treatment: A critical review